Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Single cell RNA sequencing of DHT treated human male Islet cells

ABSTRACT: Single cell RNA sequencing of DHT treated human male Islet cells

PROVIDER: PRJNA830510 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR18858546.fastq.gz	Fastqsanger.gz
	SRR18858547.fastq.gz	Fastqsanger.gz
	SRR18858548.fastq.gz	Fastqsanger.gz
	SRR18858549.fastq.gz	Fastqsanger.gz
	SRR18858550.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 12

Similar Datasets

Single cell RNA sequencing of DHT treated human male Islet cells

Project description:We analyzed DHT’s effects on the human islet cell transcriptome using single-cell RNA sequencing. We identified the four main endocrine cell subtypes, α, β, δ, pancreatic polypeptide (PPY) cells, as well as ductal, acinar, endothelial, and immune cells by unbiased graph-based clustering. Resulting data was used to evaluate differentially expressed genes across these cell clusters.

2023-04-17 | GSE201256 | GEO

Expression data from ovaries and adipose tissue in hyperandrogenized(DHT-treated) mice

Project description:Mice under chronic dihydrotestosterone (DHT) exposion represented reproductive and metabolic disorders, which were based on the dysfunction of ovaries and fat tissues. We used microarrays to detail the global programme of gene expression and identified distinct difference in ovaries and gonadal fat pads between DHT-treated mice and control.

2021-04-04 | GSE171431 | GEO

Prostate cancer organotypic slice cultures (OSC) treated with E2 or DHT

Project description:Organotypic slice cultures from prostate cancer patients were generated and treated with or without 17b-estradiol or DHT to study estrogen and androgen signalling pathways.

2020-10-06 | GSE142287 | GEO

Human scrotum and labia majora samples treated with DHT and/or AZA

Project description:Human scrotum and labia majora samples treated with DHT and/or AZA A compound treatment design type is where the response to administration of a compound or chemical (including biological compounds such as hormones) is assayed. Compound Based Treatment: dihydrotestosterone (DHT), 5-aza-deoxy-cytidine (AZA), none or both Cell Line: normal scrotum or labia majora derived from complete androgen insensitivity syndrome due to inactivating mutation of the androgen receptor gene

2009-05-20 | GSE11847 | GEO

Cisplatin exposure dysregulates pancreatic islet function in male mice

Project description:Cancer survivors have an increased risk of developing new-onset Type 2 diabetes compared to the general population. Moreover, patients treated with cisplatin, a commonly used chemotherapeutic agent, are more likely to develop metabolic syndrome and Type 2 diabetes compared to age- and sex-matched controls. Insulin-secreting β-cells—located within pancreatic islets—are critical for maintaining glucose homeostasis, and dysregulated insulin secretion is central to Type 2 diabetes pathophysiology. Surprisingly, the impact of cisplatin treatment on pancreatic islets has not been reported. In this study, we aimed to determine if murine islet function is adversely affected by direct or systemic exposure to cisplatin. In vivo cisplatin exposure led to deficits in glucose-stimulated insulin secretion in both male and female mice. In vitro cisplatin exposure to both male and female mouse islets profoundly dysregulated insulin release and reduced oxygen consumption in a non-sex specific manner. Male mouse islets exposed to cisplatin had altered the expression of genes related to insulin production, oxidative stress, and the Bcl-2 family and numerous DEGs related to the insulin secretion pathway. Our data suggest both direct and systemic cisplatin exposure cause acute defects in insulin secretion and may have lasting effects on islet health in mice.

2025-03-26 | GSE278504 | GEO

ATAC-seq on DHT treated/untreated prostate cell line RWPE1

Project description:Precise gene regulation is needed for the correct differentiation and function of cells. This is especially important when putting cells through stimuli that would change their characteristics. To understand the changes in chromatin accessibility of prostate cells when stimulating them with testosterone, we performed the ATAC-seq (Assay for Transposase Accessible Chromatin using sequencing). We have worked with the normal epithelial prostate cell line RWPE1, an heterogenous cell line composed of two subpopulations: WPE-stem (stem cell phenotype) and WPE-int (intermediate cellular subtype) and treated it with DHT. Our aim was to study haemoglobin gene regulation in prostate cells, and check whether changes in cell stimulus would lead to changes in chromatin accessibility in both haemoglobin loci. Nevertheless, the results obtained could be used to compare chromatin accessibility between DHT treated and untreated cells on any loci.

2021-09-06 | GSE183330 | GEO

LncRNA expression profiles of LNCaP cells treated with 10 nM DHT for 0 and 2 hr.

Project description:We have employed human lncRNA microarray expression profiling as a discovery platform to identify differential expression lncRNAs between DHT treated LNCaP cells and untreated cells.

2017-06-12 | GSE72866 | GEO

Cisplatin exposure dysregulates pancreatic islet function in male mice

Project description:Cisplatin exposure dysregulates pancreatic islet function in male mice

| PRJNA1167650 | ENA

ATAC-seq on DHT treated/untreated prostate cell line RWPE1

Project description:ATAC-seq on DHT treated/untreated prostate cell line RWPE1

| PRJNA760301 | ENA

scRNA-seq of siRNA treated hiPSC-derived islet cells

Project description:scRNA-seq of siRNA treated hiPSC-derived islet cells

2023-09-11 | GSE218547 | GEO